About Dr. Ankur Bahl

• Dr. Ankur Bahl is a proficient Medical Oncologist with more than 21 years of hands-on experience in treating cancer patients.
• He has rich clinical expertise in using modern treatments like immunotherapy, targeted therapy combined with chemotherapy, hormonal therapy, and palliative care to improve quality of life.
• He has led several important clinical studies and is the lead author of the largest Indian study on the use of targeted therapy (Cetuximab) for head and neck cancers.
• His work in treating acute myeloid leukemia and studying HPV patterns in India has made a big impact in cancer prevention and treatment strategies.
• Dr. Bahl completed his MBBS (2003) and MD in Medicine (20007) from Maulana Azad Medical College, followed by a DM in Medical Oncology (2012) from the prestigious AIIMS, New Delhi.
• He has also pursued advanced training in drug safety and pharmacovigilance at the University of Oxford, UK.
• His work has helped improve cancer care in India, and he regularly educates young doctors and contributes to public awareness campaigns like anti-tobacco programs.
• Dr. Bahl has founded multiple national and international cancer learning platforms, tumor boards, masterclasses, and oncology workshops.
• He is known for mentoring young oncologists and advising pharmaceutical research initiatives.
• He has numerous publications in various international and national journals.
• He is a well-known member of the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), and Indian Society of Medical and Paediatric Oncology (ISMPO).